专业监测看板

Safety and Immunogenicity of Inactivated Heterologous Booster Vaccination

药物 / 成分：VLA 2001

登记的停止原因（原文）：funding was suspended

Effect of D-cycloserine on a Short Imagery Rescripting Intervention for Subclinical PTSD

药物 / 成分：CBT + ImRs、CBT + I.E.、D-Cycloserine、Placebo

A Study to Assess Mass Balance, Pharmacokinetics (PK), and Metabolism of Orally Administered [14 C]-TAK-659 in Participants With Advanced Solid Tumor and/or Lymphoma Malignancies

药物 / 成分：[14C]-TAK-659、TAK-659

登记的停止原因（原文）：Business decision: no safety or efficacy concerns

A Study to Evaluate the Effect of Food on the Pharmacokinetics (PK) of TAK-659 in Participants With Advanced Solid Tumor

药物 / 成分：TAK-659

登记的停止原因（原文）：Business decision: no safety or efficacy concerns

A Study of TAK-659 in Combination With NKTR-214 in Participants With Advanced Non-Hodgkin Lymphoma (NHL)

药物 / 成分：TAK-659、NKTR-214

登记的停止原因（原文）：Business Decision: No Safety or Efficacy Concerns

Azacytidine During Anti-tuberculosis Therapy

药物 / 成分：Azacitidine Injection

登记的停止原因（原文）：The study was halted prematurely due to Bristol-Myers Squibb's (BMS) decision to withdraw support for this study.

Nitric Oxide Gas Inhalation for Severe Acute Respiratory Syndrome in COVID-19.

药物 / 成分：Nitric Oxide Gas、The delivery system will be set up anyway without study gas administration

登记的停止原因（原文）：The study will start to enroll patients soon

Feasibility of Treatment for Vaping Cessation

药物 / 成分：Varenicline、brief behavioral therapy

登记的停止原因（原文）：medication has not been available for the intervention

Corticosteroids in Community Acquired Pneumonia

药物 / 成分：Prednisone、Placebo

登记的停止原因（原文）：Limited enrollment due to the COVID-19 pandemic. Sponsor withdrew funding.

Efficacy,Immunogenicity and Safety of COVID-19 Vaccine , Inactivated Booster Dose in Adults Aged 18 Years and Above

药物 / 成分：Medium-dosage COVID-19 Vaccine,Inactivated、High-dosage COVID-19 Vaccine,Inactivated、Placebo-comparator group

登记的停止原因（原文）：The plan has changed